Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity

被引：1
|
作者：
Anthi, Anastasia [1 ,2 ]
Stagaki, Eleni [1 ]
Rallidis, Loukianos [1 ,3 ]
Konstantonis, Dimitrios [1 ,2 ]
Evangelopoulos, Maria-Eleftheria [4 ]
Voumvourakis, Konstantinos [5 ]
Armaganidis, Apostolos [1 ,2 ]
Orfanos, Stylianos E. [1 ,2 ]
机构：
[1] Attikon Hosp, Pulm Hypertens Clin, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Attikon Hosp, Dept Crit Care 2, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Attikon Hosp, Dept Cardiol 2, Athens, Greece
[4] Natl & Kapodistrian Univ Athens, Eginit Hosp, Dept Neurol, Demyelinating Dis Unit, Athens, Greece
[5] Natl & Kapodistrian Univ Athens, Attikon Hosp, Dept Neurol 2, Athens, Greece
来源：
ERJ OPEN RESEARCH | 2020年 / 6卷 / 01期
关键词：
D O I：
10.1183/23120541.00328-2019
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] A case of interferon-α-induced pulmonary arterial hypertension after living donor liver transplantation
    Toshiyuki Ko
    Masaru Hatano
    Daisuke Nitta
    Hironori Muraoka
    Shun Minatsuki
    Teruhiko Imamura
    Toshiro Inaba
    Hisataka Maki
    Atsushi Yao
    Koichiro Kinugawa
    Issei Komuro
    Heart and Vessels, 2016, 31 : 1206 - 1208
  • [32] Interferon-β-1aRespiratory failure secondary to pulmonary arterial hypertension: case report
    Reactions Weekly, 2016, 1624 (1) : 103 - 103
  • [33] A case of interferon-α-induced pulmonary arterial hypertension after living donor liver transplantation
    Ko, Toshiyuki
    Hatano, Masaru
    Nitta, Daisuke
    Muraoka, Hironori
    Minatsuki, Shun
    Imamura, Teruhiko
    Inaba, Toshiro
    Maki, Hisataka
    Yao, Atsushi
    Kinugawa, Koichiro
    Komuro, Issei
    HEART AND VESSELS, 2016, 31 (07) : 1206 - 1208
  • [34] Nephrotic syndrome associated with interferon-β-1b therapy for multiple sclerosis
    Kumasaka R.
    Nakamura N.
    Shirato K.
    Fujita T.
    Murakami R.
    Shimada M.
    Nakamura M.
    Osawa H.
    Yamabe H.
    Okumura K.
    Clinical and Experimental Nephrology, 2006, 10 (3) : 222 - 225
  • [35] Dual therapy in idiopathic pulmonary arterial hypertension and systemic sclerosis associated pulmonary arterial hypertension: A qualitative systematic review
    Brode, S. K.
    Johnson, S. R.
    Mielniczuk, L. M.
    Granton, J. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [36] Interferon-α/interferon-α-2bFirst report of multiple sclerosis: case report
    Reactions Weekly, 2002, 919 (1) : 7 - 7
  • [37] Interferon βPulmonary arterial hypertension: case report
    Reactions Weekly, 2015, 1577 (1) : 145 - 145
  • [38] Interferon βPulmonary arterial hypertension: case report
    Reactions Weekly, 2016, 1585 (1) : 154 - 154
  • [39] Improving Compliance with Interferon-β Therapy in Patients with Multiple Sclerosis
    Emilio Portaccio
    Maria Pia Amato
    CNS Drugs, 2009, 23 : 453 - 462
  • [40] Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients
    Koudriavtseva, T.
    Plantone, D.
    Renna, R.
    Mandoj, C.
    Mainero, C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 288 - 289
12345